Form 4 for RIGL RIGEL PHARMACEUTICALS INC
Accepted 2026-09-03 19:01:28 ET · period of report 2026-09-01 · accession 0000905148-26-004079 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-03 19:01 | 2026-09-01 | RIGL | Santos David A | EVP, Chief Commercial Off | F - Tax | $47.50 | -874 | 61.6K | -1% | -$41.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-01 | F | D | 874 | $47.50 | 61,622 | D | — | — | (F1) Includes 500 shares acquired under the Issuer's stock purchase plan. |